Switch to:
Progenics Pharmaceuticals Inc (NAS:PGNX)
Beneish M-Score
16.47 (As of Today)

Warning Sign:

Beneish M-Score 16.47 higher than -2.22, which implies that it might have manipulated its financial results.

The zones of discrimination for M-Score is as such:

An M-Score of less than -2.22 suggests that the company is not an accounting manipulator.
An M-Score of greater than -2.22 signals that the company is likely an accounting manipulator.

Progenics Pharmaceuticals Inc has a M-score of 16.47 signals that the company is a manipulator.

PGNX' s Beneish M-Score Range Over the Past 10 Years
Min: -8.74   Max: 373.91
Current: 16.47

-8.74
373.91

During the past 13 years, the highest Beneish M-Score of Progenics Pharmaceuticals Inc was 373.91. The lowest was -8.74. And the median was -1.65.


Definition

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Z-Score) or business trend (F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Progenics Pharmaceuticals Inc for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.1118+0.528 * 1.086+0.404 * 1.1078+0.892 * 23.213+0.115 * 0.5189
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.0514+4.679 * -0.0376-0.327 * 1.2129
=16.47

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

This Year (Sep16) TTM:Last Year (Sep15) TTM:
Accounts Receivable was $3.94 Mil.
Revenue was 53.85 + 8.476 + 2.45 + 5.095 = $69.87 Mil.
Gross Profit was 53.85 + 8.476 + 2.45 + 5.438 = $70.21 Mil.
Total Current Assets was $106.61 Mil.
Total Assets was $156.94 Mil.
Property, Plant and Equipment(Net PPE) was $3.90 Mil.
Depreciation, Depletion and Amortization(DDA) was $2.03 Mil.
Selling, General & Admin. Expense(SGA) was $22.40 Mil.
Total Current Liabilities was $13.82 Mil.
Long-Term Debt was $0.00 Mil.
Net Income was 36.303 + -5.638 + -12.655 + -7.147 = $10.86 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = $0.00 Mil.
Cash Flow from Operations was 38.762 + -3.538 + -7.967 + -10.486 = $16.77 Mil.
Accounts Receivable was $1.52 Mil.
Revenue was 1.396 + 1.937 + 0.248 + -0.571 = $3.01 Mil.
Gross Profit was 1.273 + 1.937 + 0.248 + -0.173 = $3.29 Mil.
Total Current Assets was $97.92 Mil.
Total Assets was $136.91 Mil.
Property, Plant and Equipment(Net PPE) was $2.43 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.52 Mil.
Selling, General & Admin. Expense(SGA) was $18.76 Mil.
Total Current Liabilities was $9.94 Mil.
Long-Term Debt was $0.00 Mil.



1. DSRI = Days Sales in Receivables Index

Measured as the ratio of days’ sales in receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3.942 / 69.871) / (1.519 / 3.01)
=0.05641826 / 0.50465116
=0.1118

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(3.285 / 3.01) / (70.214 / 69.871)
=1.09136213 / 1.00490905
=1.086

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than plant, property and equipment to total assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (106.612 + 3.899) / 156.937) / (1 - (97.924 + 2.428) / 136.912)
=0.29582571 / 0.26703284
=1.1078

4. SGI = Sales Growth Index

Ratio of sales in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=69.871 / 3.01
=23.213

5. DEPI = Depreciation Index

Measured as the ratio of the rate of depreciation in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.524 / (0.524 + 2.428)) / (2.027 / (2.027 + 3.899))
=0.17750678 / 0.34205197
=0.5189

6. SGAI = Sales, General and Administrative expenses Index

The ratio of SGA expenses in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(22.396 / 69.871) / (18.757 / 3.01)
=0.32053355 / 6.23156146
=0.0514

7. LVGI = Leverage Index

The ratio of total debt to total assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase$sgai= in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 13.822) / 156.937) / ((0 + 9.942) / 136.912)
=0.08807356 / 0.07261599
=1.2129

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(10.863 - 0 - 16.771) / 156.937
=-0.0376

An M-Score of less than -2.22 suggests that the company will not be a manipulator. An M-Score of greater than -2.22 signals that the company is likely to be a manipulator.

Progenics Pharmaceuticals Inc has a M-score of 16.47 signals that the company is likely to be a manipulator.


Related Terms

Altman Z-Score, Piotroski F-Score, Accounts Receivable, Revenue, Gross Profit, Total Current Assets, Total Assets, Property, Plant and Equipment, Depreciation, Depletion and Amortization, Selling, General & Admin. Expense, Total Current Liabilities, Long-Term Debt, Net Income, Non Operating Income, Cash Flow from Operations


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Progenics Pharmaceuticals Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
DSRI 0.07011.08510.74927.77821.86820.062327.62060.74160.0027411.8669
GMI 111.00021.00461.02630.97431.03190.964511
AQI 3.33051.4860.66960.34811.55460.56941.61755.07380.62741.529
SGI 7.36941.08210.89460.72330.162510.66350.16570.55975.64450.1955
DEPI 4.05230.65240.62270.67371.33530.96541.20741.00071.59190.9257
SGAI 0.22271.15841.15521.20385.59780.0755.03261.82520.17666.0049
LVGI 1.2360.73361.40930.21842.95340.53171.36750.50970.71751.7856
TATA -0.0751-0.0245-0.10370.1669-0.3716-0.0999-0.0103-0.0564-0.05790.0078
M-score 3.34-2.23-3.634.21-5.324.9320.69-1.730.63373.92

Progenics Pharmaceuticals Inc Quarterly Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
DSRI 2.311715.89120.00270.03240.01590.5803411.866963.019262.33630.1118
GMI 0.97160.973711.00260.99560.91460.97530.98210.99281.086
AQI 0.93810.64950.62740.82820.821.18861.5291.5491.49821.1078
SGI 0.5083.47755.64455.74556.07130.06280.19550.25410.402523.213
DEPI 1.36441.44581.59191.4731.26911.13250.92570.52160.52920.5189
SGAI 1.83060.29810.17660.18810.204219.4566.00495.04752.71360.0514
LVGI 0.6750.72120.71751.24151.41642.03051.78562.6122.44031.2129
TATA -0.02120.207-0.0579-0.0577-0.063-0.33680.0078-0.0355-0.0313-0.0376
M-score -1.8514.510.630.640.80-8.74373.9152.6852.6516.47
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK